HSDT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HSDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The historical data trend for Helius Medical Technologies's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helius Medical Technologies Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Mar16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Shiller PE Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
Helius Medical Technologies Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Shiller PE Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Helius Medical Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Helius Medical Technologies's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Helius Medical Technologies's E10 for the quarter that ended in Dec. 2023 is calculated as:
For example, Helius Medical Technologies's adjusted earnings per share data for the three months ended in Dec. 2023 was:
Adj_EPS | = | Earnings per Share (Diluted) | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | -0.96 | / | 129.4194 | * | 129.4194 | |
= | -0.960 |
Current CPI (Dec. 2023) = 129.4194.
Helius Medical Technologies Quarterly Data
Earnings per Share (Diluted) | CPI | Adj_EPS | |
201403 | -83.535 | 99.695 | -108.442 |
201406 | -350.005 | 100.560 | -450.454 |
201409 | -437.507 | 100.428 | -563.807 |
201412 | -350.005 | 99.070 | -457.228 |
201503 | -262.504 | 99.621 | -341.023 |
201506 | -350.005 | 100.684 | -449.898 |
201509 | 262.504 | 100.392 | 338.406 |
201512 | -350.005 | 99.792 | -453.917 |
201603 | -437.507 | 100.470 | -563.568 |
201606 | -350.005 | 101.688 | -445.455 |
201609 | -350.005 | 101.861 | -444.699 |
201612 | -612.509 | 101.863 | -778.210 |
201703 | -560.008 | 102.862 | -704.592 |
201706 | -542.508 | 103.349 | -679.358 |
201709 | -1,172.520 | 104.136 | -1,457.204 |
201712 | -315.005 | 104.011 | -391.956 |
201803 | -140.002 | 105.290 | -172.087 |
201806 | -1,365.020 | 106.317 | -1,661.638 |
201809 | -332.505 | 106.507 | -404.037 |
201812 | -385.006 | 105.998 | -470.078 |
201903 | -105.002 | 107.251 | -126.706 |
201906 | -17.500 | 108.070 | -20.957 |
201909 | -385.006 | 108.329 | -459.961 |
201912 | -332.505 | 108.420 | -396.906 |
202003 | -269.000 | 108.902 | -319.682 |
202006 | -145.000 | 108.767 | -172.532 |
202009 | -135.000 | 109.815 | -159.101 |
202012 | -88.501 | 109.897 | -104.223 |
202103 | -82.500 | 111.754 | -95.541 |
202106 | -129.000 | 114.631 | -145.642 |
202109 | -100.500 | 115.734 | -112.384 |
202112 | -65.500 | 117.630 | -72.065 |
202203 | -57.500 | 121.301 | -61.348 |
202206 | -48.500 | 125.017 | -50.208 |
202209 | -2.900 | 125.227 | -2.997 |
202212 | -8.500 | 125.222 | -8.785 |
202303 | -4.500 | 127.348 | -4.573 |
202306 | -3.000 | 128.729 | -3.016 |
202309 | -5.490 | 129.860 | -5.471 |
202312 | -0.960 | 129.419 | -0.960 |
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Helius Medical Technologies (NAS:HSDT) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Thank you for viewing the detailed overview of Helius Medical Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Dane Andreeff | director, 10 percent owner, officer: President and CEO | C/O ANDREEFF EQUITY ADVISORS L.L.C., 140 E. ST. LUCIA LANE, SANTA ROSA BEACH FL 32459 |
Jeffrey S Mathiesen | director, officer: CFO and Treasurer | 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167 |
Favit-van Pelt Antonella R. | officer: Chief Medical Officer | C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, NEWTOWN PA 18940 |
Paul Buckman | director | 12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402 |
Sherrie L Perkins | director | 5033 TANGLE LANE, HOUSTON TX 77056 |
Jennifer Laux | officer: Chief Commercial Officer | 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN PA 18940 |
Thomas E Griffin | director | C/O ENTELLUS MEDICAL, INC., 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447 |
Blane Walter | director | 500 OLDE WORTHINGTON ROAD, WESTERVILLE OH 43082 |
Edward M Straw | director | C/O ESTEE LAUDER COMPANIES, 767 FIFTH AVENUE, NEW YORK NY 10153 |
Joyce N Laviscount | officer: See Remarks | 100 ENDO BOULEVARD, CHADDS FORD PA 19317 |
Huaizheng Peng | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Philippe Deschamps | director, 10 percent owner, officer: President & CEO | 105 BRADFORD RD, SUITE 420, WEXFORD PA 15090 |
Mitch E Tyler | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Jonathan Sackier | 10 percent owner, officer: Chief Medical Officer | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
A&b (hk) Co Ltd | 10 percent owner | 8/F BLDG A TONGFANG INFORMATION HARBOR, NO 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN F4 518057 |
From GuruFocus
By Marketwired • 10-02-2023
By Stock market mentor Stock market mentor • 01-19-2023
By Marketwired • 08-16-2023
By sperokesalga sperokesalga • 03-02-2023
By sperokesalga sperokesalga • 04-17-2023
By sperokesalga sperokesalga • 03-22-2023
By Marketwired • 11-06-2023
By sperokesalga sperokesalga • 05-19-2023
By Stock market mentor Stock market mentor • 01-10-2023
By sperokesalga sperokesalga • 05-24-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.